title: Prenatal diagnosis of severe dermatologic diseases.
abstract: It is obvious that the nature of prenatal diagnosis of severe or lethal skin conditions is rapidly evolving. New molecular, enzymatic, and ultrastructural markers will become available. The biochemical base of many of these disorders will become known and the accuracy and utility of in utero diagnosis will improve. We wish to make one point again. The field is rapidly outpacing the ability of review articles to keep current. We urge you to refer to a genetic center for information when you are dealing with a situation in which prenatal diagnosis may be an issue.
authors.affiliation: Department of Pediatrics, University of Washington School of Medicine, Seattle.
authors.forename: V P
authors.initials: VP
authors.lastname: Sybert
authors.forename: K A
authors.initials: KA
authors.lastname: Holbrook
authors.forename: M
authors.initials: M
authors.lastname: Levy
mesh_terms: D000649:Amniocentesis; D015193:Chorionic Villi Sampling; D004820:Epidermolysis Bullosa / Q000175:diagnosis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000235:genetics; D005332:Fetoscopy; D006801:Humans; D007642:Keratosis / Q000151:congenital / Q000175:diagnosis; D010859:Pigmentation Disorders / Q000175:diagnosis; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012871:Skin Diseases / Q000175:diagnosis* / Q000235:genetics; D016216:Ultrasonography, Prenatal